HUTCHMED (China) Limited (HCM) Stock Forecast
HCM analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.58 / 5 from 12 analysts
- Price target
- $20.59 average of analyst targets
- Upside to target
- +46.6% from the latest close
- Next earnings
- —
- 52-week range
- $9.99 – $16.05
HCM analyst ratings
12 analystsNumber of analysts at each rating.
HCM price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HCM earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | $0.22 | $0.02 | $0.40 | $2.62 | −91.5% | 6 |
| Next fiscal year (2027) | $0.26 | $0.07 | $0.62 | $0.22 | +16.8% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HCM revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $626.6M | $570.0M | $727.4M | +14.2% | 23 |
| Next fiscal year (2027) | $698.8M | $594.1M | $791.4M | +11.5% | 23 |
HCM EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HCM revenue: reported and forecast
HCM EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | $0.36 | $0.26 | $0.16 | $0.20 | $0.22 | −37.5% | 2 up · 1 down |
| Next fiscal year (2027) | $0.49 | $0.36 | $0.24 | $0.26 | $0.26 | −47.5% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HCM earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HCM beat in 10 of 12.
What analysts expect from HCM
12 analysts cover HUTCHMED; their consensus rating is strong buy (4.58 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.59, 46.6% above the latest close of $14.05. Analysts expect earnings of $0.22 per share for 2026, −91.5% from a year earlier. For 2027 the average estimate is $0.26 per share on revenue of $698.8 million. HUTCHMED beat the EPS estimate in 10 of the last 12 quarters.
Related: HCM income statement, HCM key metrics, HCM chart. See the HCM stock overview for the latest quote and news.
HCM forecast FAQ
What is HUTCHMED's price target?
The average analyst price target for HUTCHMED is $20.59, 46.6% above the latest close of $14.05.
Is HUTCHMED a buy, hold or sell?
Of 12 analysts covering HUTCHMED, 9 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is HUTCHMED's EPS forecast?
Analysts forecast $0.22 per share for 2026 (range $0.02 to $0.40); for 2027 the estimate is $0.26.
What is HUTCHMED's revenue forecast?
The average revenue estimate for 2026 is $626.6 million, growth of 14.2%; for 2027 it is $698.8 million.
Does HUTCHMED usually beat earnings estimates?
HUTCHMED reported EPS at or above the analyst estimate in 10 of the last 12 quarters.